Exploring the Role of Preoperative Systemic Therapy and Primary Resection in NSCLC With Extrathoracic Metastases: Identifying the Optimal Candidates
Background In non-small cell lung cancer (NSCLC), patients with extrathoracic metastases typically have a poor prognosis, with systemic chemotherapy being the standard care. The full potential of primary resection therapy (PRT) in these patients, especially during the immunotherapy era, is not fully...
Saved in:
| Main Authors: | Xuanhong Jin MD, Xinyu Zhu MD, Hangchen Shen MD, Chongya Zhai PhD, Hongming Pan PhD, Liangkun You PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748241304973 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comment on “Surgical Margin of Resected Colorectal Liver Metastases: How Accurate Is Surgeon Prediction?”
by: Yoichiro Uchida, MD, PhD, et al.
Published: (2024-09-01) -
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
by: Song Dong, PhD, et al.
Published: (2025-01-01) -
Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC
by: Francesca Lucibello, MD, et al.
Published: (2025-01-01) -
Added Value of Liver MRI in Patients Eligible for Surgical Resection or Ablation of Colorectal Liver Metastases Based on CT: A Systematic Review and Meta-Analysis
by: Burak Görgec, MD, et al.
Published: (2024-03-01) -
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
by: Yoshihito Kogure, MD, PhD, et al.
Published: (2025-03-01)